Abstract
Therapeutic hypothermia has been adopted as a neuroprotective treatment for newborn infants
with signs of moderate or severe hypoxic-ischaemic brain damage. This article discusses one of
the new potential add-on treatments to cooling, the anaesthetic gas xenon. Its mechanism of
action, the delivery method and the on-going randomised trials investigating the neuroprotective
properties are reviewed.
with signs of moderate or severe hypoxic-ischaemic brain damage. This article discusses one of
the new potential add-on treatments to cooling, the anaesthetic gas xenon. Its mechanism of
action, the delivery method and the on-going randomised trials investigating the neuroprotective
properties are reviewed.
| Original language | English |
|---|---|
| Number of pages | 4 |
| Journal | Infant |
| Volume | 10 |
| Issue number | 1 |
| Publication status | Published - 2014 |